Skip to content
Home - Media - Press releases - 2003    
3 April 2003
ASTRAZENECA AND ADVENT INTERNATIONAL FORM STRATEGIC PARTNERSHIP

AstraZeneca UK Limited announced today the initiation of a strategic relationship with Advent International Corporation for the purpose of identifying and evaluating emerging technologies in health care and life sciences. Representatives from AstraZeneca’s Discovery and Business Development groups will work closely with Advent’s Boston-based health care team in evaluating emerging opportunities and transactions with companies in the health care and life sciences industry.

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $17.8 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index.

Advent International is one of the largest and most established private equity houses in the world whose aim is to help build market leading businesses in Europe, North America, Latin America and Asia Pacific. More information on Advent can be found at www.adventinternational.com

Further enquires to:

Media Enquiries

Steve Brown
+44 (0)20 7304 5033

Emily Denney
+44 (0)20 7304 5034


Investor Relations

Mina Blair-Robinson
+44 (0)20 7304 5084

Jonathan Hunt
+44 (0)20 7304 5087

AstraZeneca websites
Search